Comments on the pathogenesis and medical treatment of central giant cell granulomas [3]

Journal of Oral and Maxillofacial Surgery

Volumn 62, Issue 1, 2004, Pages 116-118

  Regezi, Joseph A ^a   Pogrel, M Anthony ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; CALCITONIN; CORTICOSTEROID; MONOCLONAL ANTIBODY; PROTEIN MDM2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; BONE TUMOR; CELL CYCLE; CURETTAGE; DRUG MECHANISM; DRUG TARGETING; GIANT CELL; GIANT CELL GRANULOMA; HISTOPATHOLOGY; HUMAN; LETTER; LONG BONE; MESENCHYME; OSTEOCLAST; PATHOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; SPINDLE CELL; TUMOR LOCALIZATION; VASCULAR TUMOR;

EID: 0347595336     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2003.10.005     Document Type: Letter

References (33)

1. Pogrel MA: Calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg 61:649, 2003
2. O'Malley M, Pogrel MA, Stewart JCB, et al: Central giant cell granulomas of the jaws: Phenotype and proliferation markers. J Oral Pathol Med 26:159, 1997
3. Liu B, Yu SF, Li TJ: Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med 32:367, 2003
4. Joyner CJ, Quinn JM, Triffitt JT, et al: Phenotypic characterization of mononuclear and multinucleated cells of giant cell tumor of bone. Bone Miner 16:37, 1992
5. Miyamoto N, Higuchi Y, Tajima M, et al: Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. J Orthop Res 18:647, 2000
6. Robinson D, Einhorn TA: Giant cell tumor of bone: A unique paradigm of stromal-hematopoietic cellular interactions. J Cell Biochem 55:300, 1994
7. Zheng MH, Robbins P, Xu J, et al: The histogenesis of giant cell tumor of bone: A model of interaction between neoplastic cells and osteoclasts. Histol Histopathol 16:297, 2001
8. Itonaga I, Schulze E, Burge PD, et al: Phenotypic characterization of mononuclear and multinucleated cells of giant cell reparative granuloma of small bones. J Pathol 198:30, 2002
9. Zheng MH, Xu J, Robbins P, et al: Gene expression of vascular endothelial growth factor in giant cell tumors of bone. Hum Pathol 31:804, 2000
10. Evdokiou A, Atkins GJ, Bouralexis S, et al: Expression of alternatively-spliced MDM2 transcripts in giant cell tumors of bone. Int J Oncol 19:625, 2001
11. de Souza PE, Paim JF, Carvalhais JN, et al: Immunohistochemical expression of p53, MDM2, Ki-67, and PCNA in central giant cell granuloma and giant cell tumor. J Oral Pathol Med 28:54, 1999
12. Kudo O, Sabokbar A, Pocock A, et al: Isolation of human osteoclasts formed in vitro: Hormonal effects on the bone-resorbing activity of human osteoclasts. Calcif Tissue Int 71:539, 2002
13. Zaidi M, Inzerillo AM, Moonga BS, et al: Forty years of calcitonin - where are we now? Bone 30:655, 2002
14. Miyamoto N, Higuchi Y, Tajima M, et al: Spindle-shaped cells derived from giant cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. J Orthop Res 18:647, 2000
15. Pogrel MA, Regezi JA, Harris ST, et al: Calcitonin treatment for central giant cell granulomas of the mandible: Report of two cases. J Oral Maxillofac Surg 57:848, 1999
16. Bolon B, Shalhoub V, Kostenuik PJ, et al: Osteoprotegrin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. Arthritis Rheum 46:3121, 2002
17. Buckley KA, Hipskind A, Gartland A, et al: Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. Bone 31:582, 2002
18. Nagasawa T, Kobayashi H, Kiji M, et al: LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through production of osteoprotegrin. Clin Exp Immunol 130:338, 2002
19. Atkins GJ, Haynes DR, Graves SE, et al: Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res 15:640, 2000
20. Hu Y, Yu S: Gene expression of osteoprotegrin and osteoclast differentiation factor in giant cell tumor. Zhonghua Bing Li Xue Za Zhi 31:128, 2002
21. Huang L, Xu J, Wood D, et al: Gene expression of osteoprotegrin ligand, osteoprotegrin, and receptor activator of NF-kappaB in giant cell tumor of bone. Am J Pathol 156:761, 2000
22. Roux S, Amazit L, Meduri G, et al: RANK (receptor activator in nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol 117:210, 2002
23. Rao VH, Singh RK, Delimont DC, et al: Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. Int J Oncol 14:291, 1999
24. Dodds RA, James IE, Rieman D, et al: Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. J Bone Miner Res 16:478, 2001
25. Hortobagyi GN: Novel approaches to the management of bone metastases in patients with breast cancer. Semin Oncol 29:134, 2002
26. Terpos E, Palermos J, Viniou N, et al: Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment. Calcif Tissue Int 68:285, 2001
27. Yan T, Riggs BL, Boyle WJ, et al: Regulation of osteoclastogenesis and RANK expression by TGF-beta1. J Cell Biochem 83:320, 2001
28. Zhu Z, Bohlen P, Witte L: Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics. Curr Cancer Drug Targets 2:135, 2002
29. Pegram MD, Reese DM: Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor. Semin Oncol 29:29, 2002
30. Kaban LB, Troulis MJ, Ebb D, et al: Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg 60:1103, 2002
31. Brassard DL, Grace MJ, Bordens RW: Interferon-alpha as an immunotherapeutic protein. J Leuko Biol 71:565, 2002
32. Corssmit EPM, De Metz J, Sauerwein HP, et al: Biologic responses to IFN-alpha administration in humans. J Interferon & Cytokine Res 20:1039, 2000
33. Hirayama T, Sabokbar A, Athanasou NA: Effect of corticosteroids on human osteoclast formation and activity. J Endocrinol 175:155, 2002